[Atrial fibrillation].
Atrial fibrillation is the arrhythmia that most frequently leads to hospital admission. As prevalence of atrial fibrillation increases with age, its epidemiological relevance will increase due to the well-known changes in life expectancy. In the presence of atrial fibrillation the cardiovascular mortality and the risk for a stroke are considerably elevated. Interventional treatment, such as catheter ablation or special pacemaker algorithms, have been improved extensively in the last years as a therapeutic option. Nevertheless drug therapy is still the first choice of treating atrial fibrillation.
Schueller
Per O
PO
Klinik für Kardiologie, Pneumologie und Angiologie, Medizinische Klinik und Poliklinik B der Heinrich-Heine-Universitat Düsseldorf, Moorenstr 5, 40225 Düsseldorf. schueller@med.uniduesseldorf.de
Steiner
Stephan
S
Hennersdorf
Marcus G
MG
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D010138:Pacemaker, Artificial; D012306:Risk; D020521:Stroke / Q000453:epidemiology / Q000209:etiology
D000889:Anti-Arrhythmia Agents